Michael Cremeans is an accomplished Life Sciences Industry Practice Leader at Hylant, where he has been instrumental in building and leading the company’s Life Sciences practice since October 2018. With over 39 years of professional experience, Michael has established himself as a trusted expert in the life sciences field, providing critical risk management and insurance solutions to FDA-regulated businesses. His work focuses on medical devices, pharmaceuticals, biotechnology, medical technology, and nutraceuticals, all while helping companies navigate complex regulatory environments and global risks.

Michael is known for his ability to craft robust global risk management frameworks for companies operating in the life sciences sector, including those harnessing disruptive technologies. His team excels in addressing the nuanced risks posed by regulatory and market changes, tailoring strategies to ensure that businesses can continue to innovate while managing potential liabilities. His expertise extends to simplifying and translating intricate risks into clear, actionable strategies for his clients. This includes advising on insurance and indemnification language in contracts, ensuring comprehensive protection and risk mitigation.

Before his tenure at Hylant, Michael served in leadership roles at prominent firms such as Marsh, Willis Towers Watson, and Oswald Companies. At Marsh, from 2016 to 2018, he was the Senior Vice President and Medical Device and Medical Technology Segment Leader. In this role, he authored strategic client engagement documents, led significant research projects, and created whitepapers on the evolving delivery of healthcare. He also led producer training sessions and acted as a subject matter expert on multiple prospect engagements.

From 2014 to 2016, Michael held the position of Vice President for Healthcare and Life Sciences at Willis Towers Watson, where he expanded the firm’s Life Sciences vertical and served as a strategic advisor to the Life Sciences Practice Leader. His work also involved leading research projects and providing expert guidance on prospect engagements.

Michael’s early career includes nearly two decades at Britton Gallagher, where he built a reputation as a well-known expert in medical device risk management and insurance. During his 16 years with the company, he established orthopedic medical device insurance expertise and developed specialized knowledge in FDA-regulated industries. He has held additional leadership roles, including Vice President at Neace Lukens and Life Sciences Practice Leader at Oswald Companies, where he successfully built the Life Sciences department from the ground up.

Michael’s professional expertise includes product liability, worldwide clinical trials liability, global risk management, bioethics, operational risk management, enterprise risk management, and mergers and acquisitions. His deep industry knowledge and strategic acumen have enabled him to support life sciences firms in achieving sustainable growth while mitigating risks. He has also contributed to whitepapers and blogs, sharing insights on risk analytics, insurance issues, liability concerns, and how FDA-regulated businesses can improve through data-driven strategies.

A recognized thought leader in his field, Michael frequently speaks at public events, panels, and as a guest speaker on topics such as risk management, insurance issues, and liability concerns. His experience spans international markets, with a particular focus on Europe, where he has placed insurance policies and engaged in worldwide clinical trials.

In addition to his professional accomplishments, Michael is passionate about causes related to animal welfare, politics, and science and technology. Outside of work, he enjoys spending time with his family, fishing, and focusing on fitness and health. A dedicated grandfather, Michael believes in living by the values of kindness, gratitude, and paying it forward, which he incorporates into both his personal life and professional ethos.

Michael holds a background in biology from Marshall University and continues to use his scientific foundation to inform his work in the life sciences sector. His extensive experience and commitment to helping companies navigate an increasingly complex world make him a highly sought-after advisor and leader in the industry.

Character:
Michael Cremeans is known for his perseverance and integrity, always striving to do the right thing in both personal and professional settings. His values of kindness, gratitude, and paying it forward are central to his approach to leadership and life.

Knowledge:
With over 39 years of experience in the life sciences industry, Michael has deep expertise in risk management, regulatory compliance, and FDA-regulated sectors. His broad knowledge spans medical devices, biotechnology, pharmaceuticals, and global clinical trials, making him a trusted advisor.

Strategic:
Michael excels in developing tailored risk management strategies that align with his clients’ business goals, ensuring they navigate complex regulatory and market environments successfully. His ability to simplify and translate intricate risks into actionable plans has consistently driven growth and innovation for his clients.

Communication:
A skilled communicator, Michael regularly shares his insights through public speaking, panels, and authored content. His approachable and clear communication style allows him to build strong client relationships and effectively collaborate across teams and industries.